Algeria vs Cambodia: Cause of death, by non-communicable diseases, ages 0-4
Algeria
24.4%
in 2021
Cambodia
25.3%
in 2021
Algeria rank
114th
Cambodia rank
111th
Cause of death, by non-communicable diseases, ages 0-4 over time
- Algeria
- Cambodia
How they compare
Cambodia currently reports 25.3% against 24.4% in Algeria, a difference of 0.9%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Algeria ahead.
Algeria ranks 114th and Cambodia ranks 111th of 185 countries.
Across the 3 decades both report, Algeria averaged higher in 2 and Cambodia in 1.
Head to head by decade
| Decade | Algeria | Cambodia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 16.0% | 7.9% | 8.1% | Algeria |
| 2010s | 24.1% | 18.9% | 5.2% | Algeria |
| 2020s | 24.5% | 24.9% | 0.3% | Cambodia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 0-4, Algeria or Cambodia?
- Cambodia, at 25.3% against 24.4% in Algeria as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 0-4 between Algeria and Cambodia?
- 0.9%, with Cambodia ahead.
- How many years of comparable data are there for Algeria and Cambodia?
- 6 years are reported by both, from 2000 to 2021.
- How do Algeria and Cambodia rank globally for cause of death, by non-communicable diseases, ages 0-4?
- Algeria ranks 114th and Cambodia ranks 111th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 0-4 (% of total deaths ages 0-4). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 0-4 due to non-communicable diseases divided by number of all deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.